|
No
|
Name
|
Herkunft
|
Bemerkung
|
ECACC No.
ATCC No.
|
|
1
|
|
muscle rhabdomyosarcoma
|
-
|
ATCC No: HTB-82
|
|
2
|
|
lung carcinoma
|
-
|
ATCC No: HTB-53
|
|
3
|
|
kidney carcinoma
|
-
|
ATCC No: HTB-44
|
|
4
|
|
lung carcinoma
|
lecithin producing cells
|
ATCC No: CCL-185
|
|
5
|
|
gastric, stomach
|
adenocarcinoma
|
ATCC No: CRL-1739
|
|
6
|
|
metastatic adenocarcinoma of pancreas
|
-
|
ATCC No: CRL-1682
|
|
7
|
|
placenta choriocarcinoma
|
-
|
ATCC No: CCL-98
|
|
8
|
|
mammary gland carcinoma
|
-
|
ATCC No: HTB-20
|
|
9
|
|
adenocarcinoma colorectal colon
|
-
|
ATCC No: HTB-37
|
|
10
|
|
pancreas
|
adenocarcinoma
|
ATCC No: HTB-79
|
|
11
|
|
pancreas
|
adenocarcinoma
|
ATCC No: HTB-80
|
|
12
|
|
T-lymphoblastic leukemia, peripheral blood cells
|
-
|
ATCC No: CCL-119
|
|
13
|
|
liver
|
Hela markers
|
ATCC No: CCL-13
|
|
14
|
|
gastric, stomach
|
adenocarcinoma
|
ATCC No: -
|
|
15
|
|
squamous carcinoma, mouth
|
-
|
ATCC No: -
|
|
16
|
|
Skin, Melanoma
|
-
|
ATCC No: -
|
17
|
|
prostata carcinoma
|
cerebral metastatic site
|
ATCC No: HTB-81
|
|
18
|
|
Burkitt lymphoma
|
B-Lymphoblastoid suspension cells
|
ATCC No: HTB-60
|
|
19
|
|
urinary bladder carcinoma, endothelial
|
-
|
ATCC No: CRL-1998
|
|
20
|
|
caucasian malignant melanoma, skin
|
-
|
ATCC No: CRL-1424
|
|
21
|
|
neuroblastoma, epithelial, kidney
|
-
|
ATCC No: -
|
|
22
|
|
mammalian gland epithelium
|
cells possess tandem integrated genome of SV-40
|
ATCC No: HTB-124
|
|
23
|
|
embryonal kidney cells, virus transformed
|
for adenovirus titration
|
ECACC No: 85120602
|
|
24
|
|
erythroleukemia, bone marrow
|
-
|
ATCC No: TIB-180
|
|
25
|
|
adenocarcinoma, cervix
|
-
|
ATCC No: CCL-2
|
|
26
|
|
adenocarcinoma, cervix
|
adopted to grow in suspension
|
ATCC No: CCL-2.2
|
|
27
|
|
epidermoid carcinoma, larynx
|
-
|
ATCC No: CCL-23
|
|
28
|
|
hepatocyte carcinoma, epithelial
|
-
|
ATCC No: HB 8065
|
|
29
|
|
acute promyelocytic leukemia, peripheral
blood, promyeloblast
|
-
|
ATCC No: CCL-240
|
|
30
|
|
anti colon adenocarcinoma
|
-
|
ECACC No: 91072201
ATCC No: HB 8246
|
|
31
|
|
fibrosarcoma, epithelial
|
-
|
ATCC No: CCL-121
|
|
32
|
|
liver carcinoma (Hepatoma), epithelial
|
-
|
ATCC No: -
|
|
33
|
|
cutaneous T-cell lymphoma
|
-
|
ATCC No: TIB-161
|
|
34
|
|
placenta
|
choriocarcinoma
|
ATCC No: HTB-144
|
|
35
|
|
placenta
|
choriocarcinoma
|
ATCC No: HTB-36
|
|
36
|
|
T-lymphoblastic leukemia
|
Clone E6-1
|
ATCC No: TIB-152
|
|
37
|
|
lymphoma B-cells
|
-
|
-
|
|
38
|
|
gastric carcinoma, stomach
|
metastatic site, pleural effusion; supraclavivular
and ayillary lymph nodes and Douglas cul-de-sac
|
ATCC No: HTB-103
|
|
39
|
|
prostata adenocarcinoma
|
Clone FGC
|
ATCC No: CRL-1740
|
|
40
|
|
mammary gland, adenocarcinoma
|
-
|
ATCC No: HTB-22
|
|
41
|
|
skin, melanoblastoma
|
-
|
ATCC No: -
|
|
42
|
|
skin, melanoma, metastases
|
-
|
ATCC No: -
|
43
|
|
osteosarcoma, bone, fibroblast
|
-
|
ATCC No: CRL-1427
|
|
44
|
|
T-lymphoblastic leukemia, peripheral blood cells
|
-
|
ATCC No: CRL-1552
|
|
45
|
|
T-lymphoblast, leukemia
|
-
|
ATCC No: CRL-1582
|
|
46
|
|
embryo lung
|
-
|
ATCC No: CCL-171
|
|
47
|
|
mesothelioma, biphasic
|
from metastatic site: lung
|
ATCC No: CRL-2081
|
|
48
|
|
breast, adenocarcinoma
|
-
|
-
|
|
49
|
|
Burkitt´s lymphoma
|
Secretes unknown MABs and can be used for human interferon production
|
ATCC No: CRL-1432
|
|
50
|
|
ovary, adenocarcinoma
|
-
|
ATCC No: HTB-161
|
|
51
|
|
Ovarian teratocarcinoma
|
ascitic fluid cells
|
ATCC No: CRL-1572
|
|
52
|
|
epithelioid carcinoma (pancreas)
|
cells possess phenotype for G6PD
|
ATCC No: CRL-1469
|
|
53
|
|
adenocarcinoma (prostate primary)
|
bone (metastasis)
|
ATCC No: CRL-1435
|
|
54
|
|
Burkitt´s lymphoma
|
Positive for Epstein-Barr nuclear antigen, but
does not contain the EB virus
|
ATCC No: CCL-86
|
|
55
|
Raji TK+
|
Burkitt´s lymphoma
|
Thymidin kinase positive
|
Collection of I.A.Z.
|
|
56
|
Raji TK-
|
Burkitt´s lymphoma
|
Thymidin kinase deficient
|
Collection of I.A.Z.
|
|
57
|
|
kidney
|
adult cells
|
-
|
|
58
|
|
kidney
|
-
|
-
|
|
59
|
|
rhabdomyosarkoma, muscle
|
embryo cells
|
ATCC No: CCL-136
|
|
60
|
|
lymphocytic leukemia, non-T, non-B
|
adult cells
|
ATCC No: CRL-8286
|
|
61
|
|
Peripheral blood cells from healthy male
|
Secretes immunoglobulin IgM, lambda
|
ATCC No: CCL-156
|
|
62
|
|
transitional cell papilloma, urinary bladder
|
-
|
ATCC No: HTB-2
|
|
63
|
|
adenocarcinoma, colon primary
|
-
|
ATCC No: HTB-30
|
|
64
|
|
leiomyosarcoma, vulva
|
-
|
ATCC No: HTB-88
|
|
65
|
|
malignant melanoma
|
metastasis to lymhatic system
|
ATCC No: HTB-67
|
|
66
|
|
malignant melanoma
|
skin metastasis
|
ATCC No: HTB-68
|
|
67
|
|
malignant melanoma
|
skin metastasis
|
ATCC No: HTB-70
|
|
68
|
|
malignant melanoma
|
skin
|
ATCC No: HTB-72
|
|
69
|
|
neuroblastoma, kidney
|
-
|
-
|
|
70
|
|
neurepithelioma, brain primary
|
-
|
ATCC No: HTB-10
|
|
71
|
|
adenocarcinoma (ovary primary)
|
-
|
ATCC No: HTB-77
|
|
72
|
|
colon
|
colorectal adenocarcinoma GII
|
ATCC No: CCL-233
|
|
73
|
|
adrenal gland, adenocarcinoma
|
-
|
ATCC No: CCL-105
|
|
74
|
|
bone
|
chondrosarcoma GII
|
ATCC No: HTB-94
|
|
75
|
|
colon, adenocarcinoma
|
-
|
ATCC No: CCL-228
|
|
76
|
|
fibroblast, fibrosarcoma
|
-
|
ATCC No: HTB-91
|
|
77
|
|
fibroblast, liposarcoma
|
-
|
ATCC No: HTB-92
|
|
78
|
|
fibroblast, sarcoma, synovium
|
-
|
ATCC No: HTB-93
|
|
79
|
|
urinary bladder, carcinoma
|
-
|
ATCC No: HTB-4
|
|
80
|
|
monocytic leukemia
|
-
|
ATCC No: TIB-202
|
|
81
|
|
astrocytoma, glioblastoma, brain
|
-
|
ATCC No: HTB-14
|
|
82
|
|
brain, glioblastoma
|
-
|
ATCC No: HTB-16
|
|
83
|
|
histiocytic lymphoma, macrophage
|
-
|
ATCC No: CRL-1593.2
|
|
84
|
|
lung
|
subline 2R
|
ATCC No: CCL-75.1
|
|
85
|
|
ductal carcinoma, mammary gland
|
-
|
ATCC No: CRL-1500
|